[HTML] frontiersin.org

[HTML][HTML] FBXW4 acts as a protector of FOLFOX-based chemotherapy in metastatic colorectal cancer identified by co-expression network analysis

Y Zhang, L Sun, X Wang, Y Sun, Y Chen, M Xu… - Frontiers in …, 2020 - frontiersin.org
Background FOLFOX chemotherapy is one of the most commonly used treatments for
colorectal cancer (CRC) patients. However, the efficacy and tolerance of FOLFOX therapy …
被引用次数：9 相关文章
[HTML] nih.gov

[HTML][HTML] FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis

Y Zhang, L Sun, X Wang, Y Sun, Y Chen, M Xu… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Background FOLFOX chemotherapy is one of the most commonly used treatments for
colorectal cancer (CRC) patients. However, the efficacy and tolerance of FOLFOX therapy …

FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis

Y Zhang, L Sun, X Wang, Y Sun, Y Chen… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Background FOLFOX chemotherapy is one of the most commonly used treatments for
colorectal cancer (CRC) patients. However, the efficacy and tolerance of FOLFOX therapy …

FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis.

Y Zhang, L Sun, X Wang, Y Sun, Y Chen, M Xu… - Frontiers in …, 2020 - europepmc.org
Background FOLFOX chemotherapy is one of the most commonly used treatments for
colorectal cancer (CRC) patients. However, the efficacy and tolerance of FOLFOX therapy …